These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24993329)

  • 1. A nomogram to predict loco-regional control after re-irradiation for head and neck cancer.
    Riaz N; Hong JC; Sherman EJ; Morris L; Fury M; Ganly I; Wang TJ; Shi W; Wolden SL; Jackson A; Wong RJ; Zhang Z; Rao SD; Lee NY
    Radiother Oncol; 2014 Jun; 111(3):382-7. PubMed ID: 24993329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of nomogram-based prediction of survival probability after salvage re-irradiation of head and neck cancer.
    Shikama N; Kumazaki Y; Tsukamoto N; Ebara T; Makino S; Abe T; Nakahira M; Sugasawa M; Kato S
    Jpn J Clin Oncol; 2013 Feb; 43(2):154-60. PubMed ID: 23242582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic.
    Curtis KK; Ross HJ; Garrett AL; Jizba TA; Patel AB; Patel SH; Wong WW; Halyard MY; Ko SJ; Kosiorek HE; Foote RL
    Radiat Oncol; 2016 Apr; 11():55. PubMed ID: 27061083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A competing risk nomogram to predict severe late toxicity after modern re-irradiation for squamous carcinoma of the head and neck.
    Ward MC; Lee NY; Caudell JJ; Zajichek A; Awan MJ; Koyfman SA; Dunlap NE; Zakem SJ; Hassanzadeh C; Marcrom S; Boggs DH; Isrow D; Vargo JA; Heron DE; Siddiqui F; Bonner JA; Beitler JJ; Yao M; Trotti AM; Riaz N;
    Oral Oncol; 2019 Mar; 90():80-86. PubMed ID: 30846182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage re-irradiation for recurrent head and neck cancer.
    Lee N; Chan K; Bekelman JE; Zhung J; Mechalakos J; Narayana A; Wolden S; Venkatraman ES; Pfister D; Kraus D; Shah J; Zelefsky MJ
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):731-40. PubMed ID: 17379449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
    Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors improving the outcome of patients re-irradiated with intensity-modulated radiotherapy (IMRT) for relapse or new head and neck cancer developed in irradiated areas.
    Ohnleiter T; Antoni D; Lefebvre F; Truntzer P; Schultz P; Burgy M; Borel C; Noël G
    Chin Clin Oncol; 2018 Dec; 7(6):60. PubMed ID: 30180748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory.
    Duprez F; Madani I; Bonte K; Boterberg T; Vakaet L; Derie C; De Gersem W; De Neve W
    Radiother Oncol; 2009 Dec; 93(3):563-9. PubMed ID: 19919885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses.
    Takiar V; Garden AS; Ma D; Morrison WH; Edson M; Zafereo ME; Gunn GB; Fuller CD; Beadle B; Frank SJ; William WN; Kies M; El-Naggar AK; Weber R; Rosenthal DI; Phan J
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1117-31. PubMed ID: 27354127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-irradiation Using Intensity-modulated Radiotherapy for Recurrent and Second Primary Head and Neck Cancer.
    Choi SH; Chang JS; Choi J; Park SH; Keum KC; Park KR; Lee CG
    Anticancer Res; 2018 May; 38(5):3165-3173. PubMed ID: 29715158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative.
    Ward MC; Riaz N; Caudell JJ; Dunlap NE; Isrow D; Zakem SJ; Dault J; Awan MJ; Vargo JA; Heron DE; Higgins KA; Beitler JJ; Marcrom S; Boggs DH; Hassanzadeh C; Reddy CA; Bonner JA; Yao M; Machtay M; Siddiqui F; Trotti AM; Lee NY; Koyfman SA;
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):586-594. PubMed ID: 28865925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-irradiation with interstitial pulsed-dose-rate brachytherapy for unresectable recurrent head and neck carcinoma.
    Strnad V; Lotter M; Kreppner S; Fietkau R
    Brachytherapy; 2014; 13(2):187-95. PubMed ID: 24211123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.
    Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH
    Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage stereotactic re-irradiation with CyberKnife for locally recurrent head and neck cancer: a single center experience.
    Bonomo P; Cipressi S; Iermano C; Bonucci I; Masi L; Doro R; Favuzza V; Paiar F; Simontacchi G; Meattini I; Greto D; Agresti B; Livi L; Biti G
    Tumori; 2014; 100(3):278-83. PubMed ID: 25076238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-irradiation of recurrent head and neck cancers using pulsed reduced dose rate radiotherapy: An institutional series.
    Megahed R; Prabhu AV; Mack DP; Gholami S; Samanta S; Patel M; Lewis GD
    Oral Oncol; 2024 May; 152():106778. PubMed ID: 38555751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-irradiation for recurrent and second primary cancers of the head and neck.
    Velez MA; Veruttipong D; Wang PC; Chin R; Beron P; Abemayor E; St John M; Chen AM
    Oral Oncol; 2017 Apr; 67():46-51. PubMed ID: 28351580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy.
    Rwigema JC; Heron DE; Ferris RL; Andrade RS; Gibson MK; Yang Y; Ozhasoglu C; Argiris AE; Grandis JR; Burton SA
    Am J Clin Oncol; 2011 Aug; 34(4):372-9. PubMed ID: 20859194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol.
    Pigorsch SU; Wilkens JJ; Kampfer S; Kehl V; Hapfelmeier A; Schläger C; Bier H; Schwaiger M; Combs SE
    Radiat Oncol; 2017 Mar; 12(1):45. PubMed ID: 28249612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate.
    Strojan P; Corry J; Eisbruch A; Vermorken JB; Mendenhall WM; Lee AW; Haigentz M; Beitler JJ; de Bree R; Takes RP; Paleri V; Kelly CG; Genden EM; Bradford CR; Harrison LB; Rinaldo A; Ferlito A
    Head Neck; 2015 Jan; 37(1):134-50. PubMed ID: 24481720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.